Business
SINTX AND EU CONSORTIUM COLLABORATE IN SILICON NITRIDE DEVELOPMENT
SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- SINTX Technologies, an innovative biomaterials and OEM company that develops and manufactures biomedical
About this update from Sintx Technologies, Inc.
[{"type":"text","content":"SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- SINTX Technologies, an innovative biomaterials and OEM company that develops and manufactures biomedical silicon nitride, announced a key partnership with a multi-center European industry-academic group that aims to train future scientists, and promote the development of silicon nitride biomedical implants. As partner and senior advisor to the program, SINTX will participate in technical reviews of the program, and will host graduate students during the course of the program.Program SynopsisSilicon nitride offers the mechanical strength, chemical stability, and biocompatibility needed to manufacture spinal implants. To promote research, and to train future scientists, the European Union's Horizon 2020 research and Innovation Program funded a four year (2019-2022) grant targeted specifically at developing spinal implants. Led by Professor Cecilia Persson at Uppsala University, the consortium has three university participants (Uppsala University, ETH Zürich, and University of Leeds); several industrial partners (IHI Ionbond AG, CeramTec GmbH, Key Engineering Solutions, SINTX Technologies, and OssDsign AB) and the Leeds Teaching Hospitals NHS Trust as clinical collaborators. In addition to the focus on spinal implants, the program aims to deliver 15 PhD scientists through a comprehensive, multi-center research and training effort.Persson, who is also a Board Member of the Scandinavian Society of Biomaterials, stated \"The inclusion of SINTX Technologies in this project is considered to be of very high value to the consortium, in view of their many years of experience in silicon nitride-based materials for use in biomedical applications. We have also worked with these materials for some time and find them particularly promising in certain spinal applications.\"\"This consortium is another validation of our deep bench of published research in silicon nitride. It is gratifying to see others recognize the value of silicon nitride as a biomaterial,\" said Dr. Sonny Bal, President and CEO at SINTX Technologies. \"We are honored to be an industrial partner of the European consortium, an academic and industrial collaboration that will boost our R&D, cross-fertilize our intellectual resources, expand the field, and help train future professionals.\"\"In addition to the consortium, recent pa...